Application Nr Approved Date Route Status External Links
ANDA065036 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Idarubicin Hydrochloride Injection In Combination With Other Approved Antileukemic Drugs Is Indicated For The Treatment Of Acute Myeloid Leukemia (Aml) In Adults. This Includes French-American-British (Fab) Classifications M1 Through M7.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Idarubicin Hydrochloride IDARUBICIN HYDROCHLORIDE ZINC3920266

Comments